Alyeska Investment Group’s Spero Therapeutics SPRO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-49,602	Closed	-$730K	–	818
2021 Q1	$730K	Hold	49,602	–	–	0.01%	620
2020 Q4	$962K	Sell	49,602 -50,398	-50%	-$977K	0.01%	412
2020 Q3	$1.12M	Buy	+100,000	New	+$1.12M	0.02%	380